ATE289821T1 - Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm - Google Patents

Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm

Info

Publication number
ATE289821T1
ATE289821T1 AT98926418T AT98926418T ATE289821T1 AT E289821 T1 ATE289821 T1 AT E289821T1 AT 98926418 T AT98926418 T AT 98926418T AT 98926418 T AT98926418 T AT 98926418T AT E289821 T1 ATE289821 T1 AT E289821T1
Authority
AT
Austria
Prior art keywords
colon
treating
diarrheic
disease
bacterial populations
Prior art date
Application number
AT98926418T
Other languages
English (en)
Inventor
Beth P Goldstein
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Application granted granted Critical
Publication of ATE289821T1 publication Critical patent/ATE289821T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98926418T 1997-06-09 1998-06-08 Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm ATE289821T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4923697P 1997-06-09 1997-06-09
US08/950,225 US5985823A (en) 1997-06-09 1997-10-14 Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
PCT/US1998/011820 WO1998056398A2 (en) 1997-06-09 1998-06-08 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon

Publications (1)

Publication Number Publication Date
ATE289821T1 true ATE289821T1 (de) 2005-03-15

Family

ID=26726981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98926418T ATE289821T1 (de) 1997-06-09 1998-06-08 Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm

Country Status (16)

Country Link
US (1) US5985823A (de)
EP (1) EP0983079B1 (de)
JP (1) JP2002504906A (de)
CN (1) CN1264306A (de)
AT (1) ATE289821T1 (de)
AU (1) AU7826298A (de)
BR (1) BR9810861A (de)
CA (1) CA2291645A1 (de)
DE (1) DE69829179T2 (de)
IL (1) IL132933A0 (de)
NO (1) NO996035L (de)
PL (1) PL337779A1 (de)
PT (1) PT983079E (de)
SK (1) SK169499A3 (de)
TW (1) TW505515B (de)
WO (1) WO1998056398A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete
AP2005003346A0 (en) * 2002-12-10 2005-06-30 Biosynexus Inc Topical anti-infective formulations
EP1750740A4 (de) * 2004-05-06 2009-06-10 Molichem Medicines Inc Behandlung von membran-bedingten erkrankungen und störungen unter verwendung von lantibiotikum enthaltenden zusammensetzungen
ITMI20041295A1 (it) * 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
EP1940454A4 (de) * 2005-09-28 2012-01-04 Ventria Bioscience Orale formulierung für enterische erkrankungen und/oder zur rehydratation
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
US20070238652A1 (en) * 2006-02-08 2007-10-11 Biosynexus Incorporated Neutralization of bacterial spores
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
WO2009037264A2 (en) * 2007-09-17 2009-03-26 Da Volterra Colonic delivery of antimicrobial agents
ES2520165T3 (es) * 2009-01-14 2014-11-11 Novacta Biosystems Limited Derivados de desoxiactagardina
CN102388060B (zh) 2009-02-04 2014-09-10 诺瓦克塔生物系统有限公司 阿肽加定衍生物
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
JP2013531026A (ja) 2010-07-14 2013-08-01 ノヴァクタ バイオシステムズ リミティッド Ｂ型ランチビオティックを含む製剤
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
CN105473608A (zh) * 2013-03-14 2016-04-06 阿维德百奥提克斯股份有限公司 艰难梭菌素及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
IL104364A (en) * 1992-01-17 1997-09-30 Applied Microbiology Pharmaceutical compositions containing bacteriocins
DE69629691T2 (de) * 1995-06-23 2004-02-26 Ambi, Inc. Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection

Also Published As

Publication number Publication date
PT983079E (pt) 2005-06-30
CN1264306A (zh) 2000-08-23
EP0983079A2 (de) 2000-03-08
JP2002504906A (ja) 2002-02-12
PL337779A1 (en) 2000-09-11
SK169499A3 (en) 2001-03-12
DE69829179D1 (de) 2005-04-07
WO1998056398A2 (en) 1998-12-17
DE69829179T2 (de) 2005-07-21
AU7826298A (en) 1998-12-30
BR9810861A (pt) 2001-04-24
EP0983079B1 (de) 2005-03-02
US5985823A (en) 1999-11-16
IL132933A0 (en) 2001-03-19
WO1998056398A3 (en) 1999-03-25
NO996035D0 (no) 1999-12-08
NO996035L (no) 1999-12-08
TW505515B (en) 2002-10-11
CA2291645A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
ATE289821T1 (de) Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm
NO2015027I2 (no) Mepolizumab
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
DE69636228D1 (de) Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE69626976D1 (de) BEHANDLUNG EINER PROTEINLÖSUNG MIT A1/Fe UND ANSCHLIESENDE MEMBRANKONZENTRATION
DE69634438D1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE69631381D1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ATE326964T1 (de) Aminosäurederivate zur behandlung der alzheimer- krankheit
DE69513837D1 (de) Cyklopeptolide
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
BR9604843A (pt) Peptìdeo e derivado do mesmo, e, droga e composição para tratar osteopatia
DE60041266D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
BR9611520A (pt) Composto hemo-reguladores.
ES2191778T3 (es) Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0983079

Country of ref document: EP

REN Ceased due to non-payment of the annual fee